NCT00242320 - Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119) | Biotech Hunter

Enrollment

551

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions

COPD

Interventions

DRUG

Roflumilast

to investigate the effect of 500 µg Roflumilast tablets once daily versus placebo

DRUG

Placebo

Trial Locations (32)

850

Altana Pharma/Nycomed, Quezon City

852

Altana Pharma/Nycomed, Hong Kong

870

Altana Pharma/Nycomed, Quezon City

1000

Altana Pharma/Nycomed, Manila

1100

Altana Pharma/Nycomed, Quezon City

1102

Altana Pharma/Nycomed, Quezon City

16150

Altana Pharma/Nycomed, Kota Bharu / Kelantan

50590

Altana Pharma/Nycomed, Kuala Lumpur

56000

Altana Pharma/Nycomed, Kuala Lumpur

59100

Altana Pharma/Nycomed, Kuala Lumpur

70300

Altana Pharma/Nycomed, Jalan Rasah, Seremban

88586

Altana Pharma/Nycomed, Kota Kinabalu, Sabah

Unknown

Altana Pharma/Nycomed, Shatin, NT, Hong Kong

Altana Pharma/Nycomed, Taipei

431-070

Altana Pharma/Nycomed, Anvang-Si, Gveonggi-Do

220-701

Altana Pharma/Nycomed, Gangwon-do

220-711

Altana Pharma/Nycomed, Gangwon-Do

501-757

Altana Pharma/Nycomed, Gwangju

420-767

Altana Pharma/Nycomed, Gyeonggi-do

660-702

Altana Pharma/Nycomed, Jiniu-Si. Gveongsangnam-Do

361-711

Altana Pharma/Nycomed, Jungbuk

135-720

Altana Pharma/Nycomed, Seoul

136-705

Altana Pharma/Nycomed, Seoul

137-701

Altana Pharma/Nycomed, Seoul

138-736

Altana Pharma/Nycomed, Seoul

140-757

Altana Pharma/Nycomed, Seoul

158-710

Altana Pharma/Nycomed, Seoul

480-130

Altana Pharma/Nycomed, Uijongbu-city, Gveonggi-Do

682-060

Altana Pharma/Nycomed, Ulsan

886-807

Altana Pharma/Nycomed, Kaohsiung City

886-114

Altana Pharma/Nycomed, Taipei

886-333

Altana Pharma/Nycomed, Tau-Yuan